These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11887967)

  • 21. The promises of personalized medicine.
    Cascorbi I
    Eur J Clin Pharmacol; 2010 Aug; 66(8):749-54. PubMed ID: 20563567
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency.
    Linder MW; Prough RA; Valdes R
    Clin Chem; 1997 Feb; 43(2):254-66. PubMed ID: 9023127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics.
    Wolf CR; Smith G
    Br Med Bull; 1999; 55(2):366-86. PubMed ID: 10723863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacogenetics: towards personalized medicine].
    Gurwitz D; Rehavi M
    Harefuah; 2005 Oct; 144(10):711-6, 750. PubMed ID: 16281764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical application of pharmacogenetics in pain management.
    Smith DM; Weitzel KW; Cavallari LH; Elsey AR; Schmidt SO
    Per Med; 2018 Mar; 15(2):117-126. PubMed ID: 29714124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug-Drug Interactions with Consideration of Pharmacogenetics].
    Ozawa S
    Yakugaku Zasshi; 2018; 138(3):365-371. PubMed ID: 29503430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics: past, present and future.
    Pirmohamed M
    Drug Discov Today; 2011 Oct; 16(19-20):852-61. PubMed ID: 21884816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
    Kirchheiner J; Seeringer A
    Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants.
    Thuerauf N; Lunkenheimer J
    Eur Arch Psychiatry Clin Neurosci; 2006 Aug; 256(5):287-93. PubMed ID: 16783493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced long QT syndrome.
    Letsas KP; Efremidis M; Filippatos GS; Sideris AM
    Hellenic J Cardiol; 2007; 48(5):296-9. PubMed ID: 17966685
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacogenomics and pharmacogenetics of neurodegenerative diseases: towards new targets.
    Amouyel P
    Pharmacogenomics; 2002 Jan; 3(1):1-3. PubMed ID: 11966396
    [No Abstract]   [Full Text] [Related]  

  • 32. With your genes? Take one of these, three times a day.
    Abbott A
    Nature; 2003 Oct; 425(6960):760-2. PubMed ID: 14574377
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.
    Bahar MA; Setiawan D; Hak E; Wilffert B
    Pharmacogenomics; 2017 May; 18(7):701-739. PubMed ID: 28480783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetics and cardiac ion channels.
    Roepke TK; Abbott GW
    Vascul Pharmacol; 2006 Feb; 44(2):90-106. PubMed ID: 16344000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacogenetics].
    Hach I; Kirch W
    Praxis (Bern 1994); 2008 Oct; 97(21):1127-9. PubMed ID: 18951351
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluating a newly developed pharmacogenetic array: screening in a Spanish population.
    Almoguera B; Riveiro-Alvarez R; Gomez-Dominguez B; Lopez-Rodriguez R; Dorado P; Vaquero-Lorenzo C; Dal-Ré R; Fernandez-Piqueras J; Llerena A; Abad-Santos F; Ayuso C
    Pharmacogenomics; 2010 Nov; 11(11):1619-25. PubMed ID: 21121779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update.
    Niemeijer MN; van den Berg ME; Eijgelsheim M; Rijnbeek PR; Stricker BH
    Drug Saf; 2015 Oct; 38(10):855-67. PubMed ID: 26108299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laying the foundations for personalized medicines.
    Marshall A
    Nat Biotechnol; 1997 Oct; 15(10):954-7. PubMed ID: 9335043
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacogenetics and adverse drug reactions.
    Meyer UA
    Lancet; 2000 Nov; 356(9242):1667-71. PubMed ID: 11089838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.
    Zanger UM; Raimundo S; Eichelbaum M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):23-37. PubMed ID: 14618296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.